Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Jan;70(1):50–55. doi: 10.1136/jnnp.70.1.50

Anti-GQ1b IgG antibody syndrome: clinical and immunological range

M Odaka 1, N Yuki 1, K Hirata 1
PMCID: PMC1763462  PMID: 11118247

Abstract

OBJECTIVES—To clarify the nosological relation among Miller Fisher syndrome (MFS), Guillain-Barré syndrome (GBS) with ophthalmoplegia, Bickerstaff's brain stem encephalitis (BBE), and acute ophthalmoparesis without ataxia. Serum samples from patients with each condition often have anti-GQ1b IgG antibody.
METHODS—Information on antecedent illness, initial symptoms, neurological signs during the illness, and CSF findings were reviewed in 194 patients with anti-GQ1b IgG. It was determined whether overlapping MFS and GBS (MFS/GBS), as well as overlapping BBE and GBS (BBE/GBS), is explained by the combined action of anti-GQ1b IgG and anti-GM1 or anti-GD1a IgG, serological markers of GBS.
RESULTS—Based on the diagnostic criteria, all the patients with acute ophthalmoparesis, MFS, MFS/GBS, BBE/GBS, and BBE had external ophthalmoplegia; all the patients with MFS, MFS/GBS, or GBS had hyporeflexia or areflexia; and all those with MFS and BBE showed ataxia. Tendon reflexes were decreased or absent in 91% of those with BBE/GBS, 67% of those with BBE, and 53% of those with acute ophthalmoparesis. Ataxia was present in 68% of the patients with MFS/GBS and 45% of those with BBE/GBS. Antecedent illness caused by upper respiratory tract infection had occurred in 60% to 80% of these patients, and CSF albuminocytological dissociation in 25% to 75%. Anti-GM1 or anti-GD1a IgG was present in 50% of those with GBS, 35% of those with MFS/GBS, 27% of those with BBE/GBS, 16% of those with MFS, and 8% of those with BBE.
CONCLUSIONS—These findings together with the common autoantibody (anti-GQ1b IgG) suggest that a common autoimmune mechanism functions in the pathogenesis of these illnesses. In a larger study, it was confirmed clinically that MFS, GBS, BBE, and acute ophthalmoparesis are closely related, forming a continuous range. This is supported by the immunological findings. The term "anti-GQ1b IgG antibody syndrome" is not intended to be used as a clinical diagnosis, but recognition of this syndrome is useful for understanding the aetiological relation among the various illnesses and for introducing the established treatments of GBS for use with other conditions.



Full Text

The Full Text of this article is available as a PDF (147.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Din A. N., Anderson M., Bickerstaff E. R., Harvey I. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain. 1982 Sep;105(Pt 3):481–495. doi: 10.1093/brain/105.3.481. [DOI] [PubMed] [Google Scholar]
  2. Al-Din A. S., Jamil A. S., Shakir R. Coma and brain stem areflexia in brain stem encephalitis (Fisher's syndrome). Br Med J (Clin Res Ed) 1985 Aug 24;291(6494):535–536. doi: 10.1136/bmj.291.6494.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Asbury A. K., Cornblath D. R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27 (Suppl):S21–S24. doi: 10.1002/ana.410270707. [DOI] [PubMed] [Google Scholar]
  4. Aspinall G. O., Fujimoto S., McDonald A. G., Pang H., Kurjanczyk L. A., Penner J. L. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun. 1994 May;62(5):2122–2125. doi: 10.1128/iai.62.5.2122-2125.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BICKERSTAFF E. R. Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis. Br Med J. 1957 Jun 15;1(5032):1384–1387. doi: 10.1136/bmj.1.5032.1384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BICKERSTAFF E. R., CLOAKE P. C. P. Mesencephalitis and rhombencephalitis. Br Med J. 1951 Jul 14;2(4723):77–81. doi: 10.1136/bmj.2.4723.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buchwald B., Toyka K. V., Zielasek J., Weishaupt A., Schweiger S., Dudel J. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study. Ann Neurol. 1998 Dec;44(6):913–922. doi: 10.1002/ana.410440610. [DOI] [PubMed] [Google Scholar]
  8. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997 Jan 16;745(1-2):32–36. doi: 10.1016/s0006-8993(96)01123-7. [DOI] [PubMed] [Google Scholar]
  9. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993 Oct;43(10):1911–1917. doi: 10.1212/wnl.43.10.1911. [DOI] [PubMed] [Google Scholar]
  10. Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992 Jun;31(6):677–679. doi: 10.1002/ana.410310619. [DOI] [PubMed] [Google Scholar]
  11. Constant O. C., Bentley C. C., Denman A. M., Lehane J. R., Larson H. E. The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect. 1983 Jan;6(1):89–91. doi: 10.1016/s0163-4453(83)95881-4. [DOI] [PubMed] [Google Scholar]
  12. FISHER M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956 Jul 12;255(2):57–65. doi: 10.1056/NEJM195607122550201. [DOI] [PubMed] [Google Scholar]
  13. Ho T. W., Willison H. J., Nachamkin I., Li C. Y., Veitch J., Ung H., Wang G. R., Liu R. C., Cornblath D. R., Asbury A. K. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol. 1999 Feb;45(2):168–173. doi: 10.1002/1531-8249(199902)45:2<168::aid-ana6>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  14. Jacobs B. C., Rothbarth P. H., van der Meché F. G., Herbrink P., Schmitz P. I., de Klerk M. A., van Doorn P. A. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998 Oct;51(4):1110–1115. doi: 10.1212/wnl.51.4.1110. [DOI] [PubMed] [Google Scholar]
  15. Kikuchi M., Tagawa Y., Iwamoto H., Hoshino H., Yuki N. Bickerstaff's brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy. J Child Neurol. 1997 Sep;12(6):403–405. doi: 10.1177/088307389701200612. [DOI] [PubMed] [Google Scholar]
  16. Kikuchi M., Tagawa Y., Saotome S., Nonoyama T., Hoshino H., Yuki N. Acute ophthalmoparesis associated with IgG anti-GQ1b antibody subsequent to Streptococcus pyogenes infection. Eur J Paediatr Neurol. 1997;1(1):47–48. doi: 10.1016/s1090-3798(97)80011-6. [DOI] [PubMed] [Google Scholar]
  17. Koga M., Yuki N., Takahashi M., Saito K., Hirata K. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes. J Neuroimmunol. 1998 Jan;81(1-2):138–143. doi: 10.1016/s0165-5728(97)00168-9. [DOI] [PubMed] [Google Scholar]
  18. Kornberg A. J., Pestronk A., Bieser K., Ho T. W., McKhann G. M., Wu H. S., Jiang Z. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol. 1994 Feb;35(2):234–237. doi: 10.1002/ana.410350217. [DOI] [PubMed] [Google Scholar]
  19. Kusunoki S., Chiba A., Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve. 1999 Aug;22(8):1071–1074. doi: 10.1002/(sici)1097-4598(199908)22:8<1071::aid-mus10>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  20. Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M., Noda M. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol. 1998 Aug;44(2):202–208. doi: 10.1002/ana.410440210. [DOI] [PubMed] [Google Scholar]
  21. Nagaoka U., Kato T., Kurita K., Arawaka S., Hosoya T., Yuki N., Shikama Y., Yamaguchi K., Sasaki H. Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome. Neurology. 1996 Dec;47(6):1601–1602. doi: 10.1212/wnl.47.6.1601. [DOI] [PubMed] [Google Scholar]
  22. Odaka M., Yuki N., Hirata K. Bilateral ballism in a patient with overlapping Fisher's and Guillain-Barré syndromes. J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):206–208. doi: 10.1136/jnnp.67.2.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Odaka M., Yuki N., Yoshino H., Kasama T., Handa S., Irie F., Hirabayashi Y., Suzuki A., Hirata K. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol. 1998 Jun;43(6):829–834. doi: 10.1002/ana.410430619. [DOI] [PubMed] [Google Scholar]
  24. Ohtsuka K., Nakamura Y., Hashimoto M., Tagawa Y., Takahashi M., Saito K., Yuki N. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni. Ophthalmology. 1998 Jul;105(7):1281–1285. doi: 10.1016/S0161-6420(98)97034-8. [DOI] [PubMed] [Google Scholar]
  25. Plomp J. J., Molenaar P. C., O'Hanlon G. M., Jacobs B. C., Veitch J., Daha M. R., van Doorn P. A., van der Meché F. G., Vincent A., Morgan B. P. Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol. 1999 Feb;45(2):189–199. doi: 10.1002/1531-8249(199902)45:2<189::aid-ana9>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  26. Rees J. H., Gregson N. A., Hughes R. A. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol. 1995 Nov;38(5):809–816. doi: 10.1002/ana.410380516. [DOI] [PubMed] [Google Scholar]
  27. Ropper A. H. The CNS in Guillain-Barré syndrome. Arch Neurol. 1983 Jul;40(7):397–398. doi: 10.1001/archneur.1983.04050070027003. [DOI] [PubMed] [Google Scholar]
  28. Slavin M. L. Gaze palsy associated with viral syndrome. Am J Ophthalmol. 1985 Sep 15;100(3):468–473. doi: 10.1016/0002-9394(85)90516-1. [DOI] [PubMed] [Google Scholar]
  29. Tanaka H., Yuki N., Hirata K. Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome. Am J Ophthalmol. 1998 Aug;126(2):322–324. doi: 10.1016/s0002-9394(98)00161-5. [DOI] [PubMed] [Google Scholar]
  30. Willison H. J., Veitch J., Paterson G., Kennedy P. G. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204–206. doi: 10.1136/jnnp.56.2.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol. 1996 May;39(5):668–672. doi: 10.1002/ana.410390517. [DOI] [PubMed] [Google Scholar]
  32. Yuki N., Hirata K. Fisher's syndrome and group A streptococcal infection. J Neurol Sci. 1998 Sep 18;160(1):64–66. doi: 10.1016/s0022-510x(98)00220-2. [DOI] [PubMed] [Google Scholar]
  33. Yuki N., Hirata K. Preserved tendon reflexes in Campylobacter neuropathy. Ann Neurol. 1998 Apr;43(4):546–547. doi: 10.1002/ana.410430424. [DOI] [PubMed] [Google Scholar]
  34. Yuki N., Ichihashi Y., Taki T. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J Neuroimmunol. 1995 Jul;60(1-2):161–164. doi: 10.1016/0165-5728(95)00052-4. [DOI] [PubMed] [Google Scholar]
  35. Yuki N., Sato S., Tsuji S., Hozumi I., Miyatake T. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci. 1993 Aug;118(1):83–87. doi: 10.1016/0022-510x(93)90250-3. [DOI] [PubMed] [Google Scholar]
  36. Yuki N., Sato S., Tsuji S., Ohsawa T., Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology. 1993 Feb;43(2):414–417. doi: 10.1212/wnl.43.2.414. [DOI] [PubMed] [Google Scholar]
  37. Yuki N. Successful plasmapheresis in Bickerstaff's brain stem encephalitis associated with anti-GQ1b antibody. J Neurol Sci. 1995 Jul;131(1):108–110. doi: 10.1016/0022-510x(95)00112-f. [DOI] [PubMed] [Google Scholar]
  38. Yuki N., Takahashi M., Tagawa Y., Kashiwase K., Tadokoro K., Saito K. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome. Ann Neurol. 1997 Jul;42(1):28–33. doi: 10.1002/ana.410420107. [DOI] [PubMed] [Google Scholar]
  39. Yuki N., Taki T., Takahashi M., Saito K., Yoshino H., Tai T., Handa S., Miyatake T. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol. 1994 Nov;36(5):791–793. doi: 10.1002/ana.410360517. [DOI] [PubMed] [Google Scholar]
  40. Yuki N. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: A new approach to treatment. Neurology. 1996 Jun;46(6):1644–1651. doi: 10.1212/wnl.46.6.1644. [DOI] [PubMed] [Google Scholar]
  41. Yuki N., Wakabayashi K., Yamada M., Seki K. Overlap of Guillain-Barre syndrome and Bickerstaff's brainstem encephalitis. J Neurol Sci. 1997 Jan;145(1):119–121. doi: 10.1016/s0022-510x(96)00251-1. [DOI] [PubMed] [Google Scholar]
  42. al-Din S. N., Anderson M., Eeg-Olofsson O., Trontelj J. V. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol Scand. 1994 Mar;89(3):157–163. doi: 10.1111/j.1600-0404.1994.tb01654.x. [DOI] [PubMed] [Google Scholar]
  43. vd Kruijk R. A., Lampe A. S., Endtz H. P. Bilateral abducens paresis following Campylobacter jejuni enteritis. J Infect. 1992 Mar;24(2):215–216. doi: 10.1016/0163-4453(92)93136-e. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES